CoinInsight360.com logo CoinInsight360.com logo
America's Social Casino

crypto.news 2025-06-20 14:11:12

Parataxis seals $18m deal to launch Bitcoin treasury on KOSDAQ

Following the lead of Strategy and Japan’s Metaplanet, Parataxis is bringing Wall Street’s Bitcoin treasury strategy to Korea with an $18 million takeover of Bridge Bio, signaling deeper institutional crypto penetration. In a press release on June 20, Parataxis Holdings LLC announced its acquisition of a controlling stake in Bridge Biotherapeutics for KRW 25 billion (about $18 million). The deal, pending shareholder approval, will see the biotech outfit rebranded as Parataxis Korea, a publicly traded, Bitcoin ( BTC )-native treasury company listed on South Korea’s KOSDAQ exchange. Edward Chin, Parataxis’ founder, and Andrew Kim, a partner at its affiliate Parataxis Capital, will join the board, with Kim stepping in as CEO. You might also like: Bank of England Governor casts doubt on the case for retail CBDC Bitcoin’s corporate wave hits Korea Parataxis Korea plans to deploy an institutional-grade Bitcoin treasury strategy built around disciplined capital allocation, governance transparency, and long-term accumulation. “We are incredibly excited to create the first BTC treasury company in South Korea backed by an institutional-grade platform. Given the strategic nature of BTC on the global stage and its finite supply, we believe that building and growing a company like Parataxis Korea and accumulating a BTC treasury will benefit our shareholders as well as the country over the long run,” Chin stated. According to Parataxis executives, the soon-to-be-renamed successor of Bridge Biotherapeutics will be structured as a hybrid to retain its biotech arm while adding a BTC-centric financial strategy layered on top. James Jungkue Lee, co-founder of Bridge Bio, will lead the core biotech business. Parataxis is joining an established movement. The company points to Strategy’s massive 582,000 BTC treasury and Metaplanet’s 10,000 BTC holdings as successful precedents for their Korean venture. And the trend is growing: according to Standard Chartered, at least 61 publicly listed firms not native to crypto have adopted Bitcoin treasury strategies in recent months, a number that has doubled since April, underscoring how BTC is emerging as an alternative, not speculative, reserve asset for established companies. For all the enthusiasm, the strategy isn’t without risks. Charles Schwab’s recent analysis warns that companies overexposed to Bitcoin risk liquidity crunches if prices plummet. Standard Chartered estimates a drop below $90,000 could wipe out half of corporate BTC treasuries. Read more: CZ warns of AI deepfakes as more execs fall victim to Lazarus-linked zoom hacks

Leggi la dichiarazione di non responsabilità : Tutti i contenuti forniti nel nostro sito Web, i siti con collegamento ipertestuale, le applicazioni associate, i forum, i blog, gli account dei social media e altre piattaforme ("Sito") sono solo per le vostre informazioni generali, procurati da fonti di terze parti. Non rilasciamo alcuna garanzia di alcun tipo in relazione al nostro contenuto, incluso ma non limitato a accuratezza e aggiornamento. Nessuna parte del contenuto che forniamo costituisce consulenza finanziaria, consulenza legale o qualsiasi altra forma di consulenza intesa per la vostra specifica dipendenza per qualsiasi scopo. Qualsiasi uso o affidamento sui nostri contenuti è esclusivamente a proprio rischio e discrezione. Devi condurre la tua ricerca, rivedere, analizzare e verificare i nostri contenuti prima di fare affidamento su di essi. Il trading è un'attività altamente rischiosa che può portare a perdite importanti, pertanto si prega di consultare il proprio consulente finanziario prima di prendere qualsiasi decisione. Nessun contenuto sul nostro sito è pensato per essere una sollecitazione o un'offerta